503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-11.69%
Revenue decline while ORCL shows 0.68% growth. Joel Greenblatt would examine competitive position erosion.
-29.04%
Cost reduction while ORCL shows 0.40% growth. Joel Greenblatt would examine competitive advantage.
-6.89%
Gross profit decline while ORCL shows 0.76% growth. Joel Greenblatt would examine competitive position.
5.43%
Margin expansion exceeding 1.5x ORCL's 0.08%. David Dodd would verify competitive advantages.
7.96%
R&D growth above 1.5x ORCL's 1.19%. Michael Burry would check for spending discipline.
119.61%
G&A change of 119.61% while ORCL maintains overhead. Bruce Berkowitz would investigate efficiency.
-6.99%
Both companies reducing marketing spend. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
18.73%
Operating expenses growth while ORCL reduces costs. John Neff would investigate differences.
1.61%
Total costs growth above 1.5x ORCL's 0.09%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
10.60%
D&A growth while ORCL reduces D&A. John Neff would investigate differences.
-31.97%
EBITDA decline while ORCL shows 1.38% growth. Joel Greenblatt would examine position.
-20.97%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-31.97%
Operating income decline while ORCL shows 5.22% growth. Joel Greenblatt would examine position.
-22.97%
Operating margin decline while ORCL shows 4.51% growth. Joel Greenblatt would examine position.
18.29%
Other expenses growth while ORCL reduces costs. John Neff would investigate differences.
-29.47%
Pre-tax income decline while ORCL shows 3.42% growth. Joel Greenblatt would examine position.
-20.14%
Pre-tax margin decline while ORCL shows 2.72% growth. Joel Greenblatt would examine position.
-80.03%
Tax expense reduction while ORCL shows 4.88% growth. Joel Greenblatt would examine advantage.
-6.78%
Net income decline while ORCL shows 2.84% growth. Joel Greenblatt would examine position.
5.56%
Net margin growth exceeding 1.5x ORCL's 2.15%. David Dodd would verify competitive advantages.
-6.00%
EPS decline while ORCL shows 4.00% growth. Joel Greenblatt would examine position.
-6.00%
Diluted EPS decline while ORCL shows 4.00% growth. Joel Greenblatt would examine position.
-0.58%
Share count reduction while ORCL shows 0.45% change. Joel Greenblatt would examine strategy.
-0.79%
Diluted share reduction while ORCL shows 0.06% change. Joel Greenblatt would examine strategy.